These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4384520)

  • 1. Adverse reactions to salicylazosulfapyridine (azulfidine) in the treatment of ulcerative colitis.
    Collins JR
    South Med J; 1968 Apr; 61(4):354-8. PubMed ID: 4384520
    [No Abstract]   [Full Text] [Related]  

  • 2. Adverse reactions during salicylazosulfapyridine therapy and the relation with drug metabolism and acetylator phenotype.
    Das KM; Eastwood MA; McManus JP; Sircus W
    N Engl J Med; 1973 Sep; 289(10):491-5. PubMed ID: 4146729
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hemolysis, formation of Heinz bodies and of methemoglobin under therapy with Azulfidine (author's transl)].
    Kater F
    Med Klin; 1974 Mar; 69(11):466-8. PubMed ID: 4151648
    [No Abstract]   [Full Text] [Related]  

  • 4. [Side effects of salicylazosulfapyridine therapy].
    Miller B
    Dtsch Med Wochenschr; 1980 Nov; 105(46):1596-7. PubMed ID: 6108200
    [No Abstract]   [Full Text] [Related]  

  • 5. [Salicylazosulfapyridine-induced agranulocytosis in a patient with ulcerative colitis, successfully treated with granulocyte colony-stimulating factor].
    Matsubayashi Y; Izumi Y; Mori Y; Itoh K; Morioka A; Tatsuta H; Hashimoto A; Kotera T; Itoh A; Jo I
    Nihon Shokakibyo Gakkai Zasshi; 1991 Jan; 88(1):87-90. PubMed ID: 1709218
    [No Abstract]   [Full Text] [Related]  

  • 6. [Agranulocytosis in patients with ulcerative colitis treated with salazosulphapyridine].
    Søndergaard JO; Stage JG; Sprechler M
    Ugeskr Laeger; 1983 Jul; 145(29):2225-7. PubMed ID: 6137093
    [No Abstract]   [Full Text] [Related]  

  • 7. AGRANULOCYTOSIS DUE TO ADMINISTRATION OF SALICYLAZOSULFAPYRADINE (AZULFIDINE).
    PANITZ F
    Med Bull US Army Eur; 1963 Sep; 20():270-1. PubMed ID: 14044337
    [No Abstract]   [Full Text] [Related]  

  • 8. [Remission for a patient with ulcerative colitis after agranulocytosis by the side effect of salazosulfapyridine].
    Nakamura K; Takeshima F; Shiozawa K; Furusu H; Tomonaga M; Isomoto H; Ohmagari K; Mizuta Y; Murase K; Kohno S
    Nihon Naika Gakkai Zasshi; 2000 Jan; 89(1):139-41. PubMed ID: 10723929
    [No Abstract]   [Full Text] [Related]  

  • 9. Adverse effects of sulfasalazine and treatment of ulcerative colitis with mesalazine.
    Nakajima H; Munakata A; Yoshida Y
    J Gastroenterol; 1995 Nov; 30 Suppl 8():115-7. PubMed ID: 8563870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulfasalazine-induced agranulocytosis.
    Jacobson IM; Kelsey PB; Blyden GT; Demirjian ZN; Isselbacher KJ
    Am J Gastroenterol; 1985 Feb; 80(2):118-21. PubMed ID: 2857524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granulomatous hepatitis associated with salicylazosulfapyridine therapy.
    Callen JP; Soderstrom RM
    South Med J; 1978 Sep; 71(9):1159-60. PubMed ID: 28568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Granulocytopenia in treatment with salazopyrin].
    Kvarstein G; Hovdenak N
    Tidsskr Nor Laegeforen; 1988 Nov; 108(32):2982-3. PubMed ID: 2908084
    [No Abstract]   [Full Text] [Related]  

  • 13. Desensitization of patients with inflammatory bowel disease to sulfasalazine.
    Taffet SL; Das KM
    Am J Med; 1982 Oct; 73(4):520-4. PubMed ID: 6127032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxic epidermal necrolysis, agranulocytosis and erythroid hypoplasia associated with sulphasalazine.
    Maddocks JL; Slater DN
    J R Soc Med; 1980 Aug; 73(8):587-8. PubMed ID: 6112274
    [No Abstract]   [Full Text] [Related]  

  • 15. [Salicylazosulfapyridine-induced male infertility in a patient with ulcerative colitis].
    Chiba M; Igarashi K; Masamune O; Ito Y
    Nihon Shokakibyo Gakkai Zasshi; 1989 Jan; 86(1):88-90. PubMed ID: 2567362
    [No Abstract]   [Full Text] [Related]  

  • 16. Azulfidine therapy for ulcerative colitis in infancy.
    Liebman WM
    South Med J; 1979 Apr; 72(4):477-9. PubMed ID: 34887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effectiveness of packaged salicylazosulfapyridine (Azulfidine)-enema in proctitis, proto-sigmoiditis and left-sided colitis].
    Frühmorgen P
    Z Gastroenterol Verh; 1981 Jun; 19():36-7. PubMed ID: 6168132
    [No Abstract]   [Full Text] [Related]  

  • 18. Impaired folic acid absorption in inflammatory bowel disease: effects of salicylazosulfapyridine (Azulfidine).
    Franklin JL; Rosenberg HH
    Gastroenterology; 1973 Apr; 64(4):517-25. PubMed ID: 4144775
    [No Abstract]   [Full Text] [Related]  

  • 19. Ulcerative colitis and erythrocyte G6PD deficiency. Salicylazosulfapyridine-provoked hemolysis.
    Cohen SM; Rosenthal DS; Karp PJ
    JAMA; 1968 Aug; 205(7):528-30. PubMed ID: 4386139
    [No Abstract]   [Full Text] [Related]  

  • 20. [Toxic phlebitis of the retina in therapy with salazosulfapyridine (Azulfidine)].
    Duncker G; Gronemeyer U; Kolenda KD
    Fortschr Ophthalmol; 1985; 82(3):288-9. PubMed ID: 2863203
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.